论文信息 - Repurposing the HCV NS3–4A protease drug boceprevir as COVID-19 therapeutics - 字舞流文

Repurposing the HCV NS3–4A protease drug boceprevir as COVID-19 therapeutics

A. Dömling | F. Reggiori | M. Groves | C. Neochoritis | M. Velasco-Velázquez | Yingying Cong | A. Ruiz-Moreno | R. Oerlemans | N. Dinesh Kumar | Jolanda Smith